Nearly 40% of Cancer Clinical Trials Disrupted By COVID-19 Are Restarting; Guidance for Patients

Published Aug 17, 2020

Nearly 40% of Cancer Clinical Trials Disrupted By COVID-19 Are Restarting; Guidance for Patients

Patients and doctors are encouraged that clinical trials have started up again. A leading expert talks to SurvivorNet about why you shouldn't be afraid to consider a clinical trial during the outbreak.

NOW
PLAYING
Community Medical Center Shutting Out New Patients Due to COVID Clusters
NOW
PLAYING
"A Second Opportunity at Life"-- Maribel Ramos Is Thriving 5 Years After Experimental Immunotherapy for Triple-Negative Breast Cancer
NOW
PLAYING
Black Americans Don't Get Screened or Treated for Lung Cancer at the Same Rates as White Americans: Here's Why, and What We Can Do About It
NOW
PLAYING
5 COVID-19 Vaccine Questions Answered by Expert Physician
NOW
PLAYING
Outrage Over Lack of COVID-19 Vaccines as People With Cancer Struggle to Get It: 3 Things to Try
NOW
PLAYING
"No, You Won't Be Radioactive" & 4 Other Answers to Frequently Asked Questions Around Radiation Treatment

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.